Page 1296 - Small Animal Internal Medicine, 6th Edition

1268 PART XII Oncology

zoledronate (at a dosage of 0.1 mg/kg administered intrave-
TABLE 75.2 nously q3-8 weeks) in dogs with tumor-associated hypercal-
VetBooks.ir Analgesics Commonly Used in Dogs With Cancer cemia in which the neoplastic disease could not be surgically
removed or that had failed chemotherapy. In most dogs,
serum calcium concentrations were maintained within
DRUG
BRAND
DOSAGE
normal limits, and no appreciable toxicity was detected.
Nonsteroidal Antiinflammatories In addition, pain control has recently contributed mark-
Carprofen Rimadyl 1-2 mg/kg PO q12h edly to improving the QOL in small animal cancer patients.
Deracoxib Deramaxx 1 mg/kg PO q24h Opioids, nonsteroidal antiinflammatories, and other drugs
Meloxicam Metacam 0.1-0.2 mg/kg PO q24h have resulted in excellent clinical results (Table 75.2).
Finally, most cats and dogs with cancer are treated using
Firocoxib Previcox 5 mg/kg PO q24h
a team approach. This team includes the pet, family, medical
Piroxicam Feldene 0.3 mg/kg PO q24-48h oncologist, oncologic nurse, surgical oncologist, radiothera-
pist, clinical pathologist, and anatomic pathologist. A smooth
Opioids
interaction among the members of the team results in
Tramadol Ultram 1-4 mg/kg PO q8-12h marked benefits for the pet and its owner.
Buprenorphine Buprenex 0.01-0.03 mg/kg PO or
SC q8-12h
Suggested Readings
Aiken SW. Principles of surgery for the cancer patient. Clin Tech
Small Anim Pract. 2003;18:75.
adenocarcinoma of the anal sac and metastatic sublumbar Couto CG. Principles of cancer treatment. In: Nelson R, Couto CG,
lymphadenopathy benefit from surgical resection of the eds. Small animal internal medicine. 4th ed. St Louis: Elsevier;
2009:1150.
primary tumor and/or metastatic nodes, even if adjuvant Eisenhauer EA, et al. New response evaluation criteria in solid
chemotherapy is not being considered. Removal of the tumours: revised RECIST guideline (version 1.1). Eur J Cancer.
primary mass improves clinical signs of straining in these 2009;45:228.
patients; because the colon and rectum are compressed ven- Lagoni L, et al. The human-animal bond and grief. Philadelphia: WB
trally by the enlarged lymph nodes and laterally or dorsally Saunders; 1994.
by the primary mass, the removal of one of the lesions easily Lynch S, et al. Development of a questionnaire assessing health-
alleviates clinical signs. Sublumbar (or iliac) lymphadenec- related quality-of-life in dogs and cats with cancer. Vet Comp
tomy and chemotherapy in dogs with metastatic apocrine Oncol. 2011;9:172.
gland adenocarcinoma of the anal sacs in the author’s clinic McEntee MC. Veterinary radiation therapy: review and current
result in survival times of 1 to 3 years. state of the art. J Am Anim Hosp Assoc. 2006;42:94.
Needless to say, the clinician should also address the Page RL, et al. Clinical indications and applications of radiotherapy
presence of paraneoplastic syndromes even if specific anti- and hyperthermia in veterinary oncology. Vet Clin North Am
Small Anim Pract. 1990;20:1075.
neoplastic therapy is not contemplated. For example, treat- Vail DM, et al. Response evaluation criteria for peripheral nodal
ment of hypercalcemia of malignancy with bisphosphonates lymphoma in dogs (v1.0)—a veterinary cooperative oncology
causes remarkable improvement in the QOL of affected dogs. group (VCOG) consensus document. Vet Comp Oncol. 2010;8:28.
The authors’ clinics have used pamidronate (at a dosage Withrow SJ. The three rules of good oncology: biopsy! biopsy!
of 1-2 mg/kg, administered intravenously q6-8 weeks) or biopsy! J Am Anim Hosp Assoc. 1991;27:311.